Search research articles
Contact Us
Filters
Showing results (61-70 of 201) with videos related to
Page
of 21
Sort By:
Springerplus
|
June 18, 2014
Comparison of treatment patterns and economic outcomes in metastatic breast cancer patients initiated on trastuzumab versus lapatinib: a retrospective analysis
Annie Guérin, Deepa Lalla, Geneviève Gauthier, et al.
Experimental Hematology & Oncology
|
December 23, 2015
Clinical outcomes among HR+/HER2- metastatic breast cancer patients with multiple metastatic sites: a chart review study in the US
Jipan Xie, Yanni Hao, Nanxin Li, et al.
International Journal of Breast Cancer
|
June 17, 2015
Everolimus-Based Therapy versus Chemotherapy among Patients with HR+/HER2- Metastatic Breast Cancer: Comparative Effectiveness from a Chart Review Study
Nanxin Li, Yanni Hao, Jipan Xie, et al.
Managed Care (Langhorne, Pa.)
|
February 16, 2012
Treatment persistence & health care costs of adult MDD patients treated with escitalopram vs. citalopram in a medicaid population
Eric Q Wu, Rym Ben-Hamadi, Mei Lu, et al.
Circulation. Cardiovascular Quality and Outcomes
|
December 6, 2012
Cost-effectiveness of hub-and-spoke telestroke networks for the management of acute ischemic stroke from the hospitals' perspectives
Jeffrey A Switzer, Bart M Demaerschalk, Jipan Xie, et al.
Current Medical Research and Opinion
|
November 11, 2010
Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemia
Eric Q Wu, Annie Guerin, Andrew P Yu, et al.
The American Journal of Managed Care
|
February 12, 2014
Cost utility of hub-and-spoke telestroke networks from societal perspective
Bart M Demaerschalk, Jeffrey A Switzer, Jipan Xie, et al.
Diabetes Care
|
June 27, 2013
Clinical and economic benefits associated with the achievement of both HbA1c and LDL cholesterol goals in veterans with type 2 diabetes
Lizheng Shi, Xin Ye, Mei Lu, et al.
Journal of Managed Care Pharmacy : JMCP
|
September 19, 2007
Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies
Eric Q Wu, Howard G Birnbaum, Huabin F Zhang, et al.
Journal of Medical Economics
|
April 30, 2013
Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis
Juliana Setyawan, Paul Hodgkins, Annie Guérin, et al.
Page
of 21
Search research articles
Search
Showing results (61-70 of 201) with videos related to
Sort By:
Page
of 21
Springerplus
|
June 18, 2014
Comparison of treatment patterns and economic outcomes in metastatic breast cancer patients initiated on trastuzumab versus lapatinib: a retrospective analysis
Annie Guérin, Deepa Lalla, Geneviève Gauthier, et al.
Experimental Hematology & Oncology
|
December 23, 2015
Clinical outcomes among HR+/HER2- metastatic breast cancer patients with multiple metastatic sites: a chart review study in the US
Jipan Xie, Yanni Hao, Nanxin Li, et al.
International Journal of Breast Cancer
|
June 17, 2015
Everolimus-Based Therapy versus Chemotherapy among Patients with HR+/HER2- Metastatic Breast Cancer: Comparative Effectiveness from a Chart Review Study
Nanxin Li, Yanni Hao, Jipan Xie, et al.
Managed Care (Langhorne, Pa.)
|
February 16, 2012
Treatment persistence & health care costs of adult MDD patients treated with escitalopram vs. citalopram in a medicaid population
Eric Q Wu, Rym Ben-Hamadi, Mei Lu, et al.
Circulation. Cardiovascular Quality and Outcomes
|
December 6, 2012
Cost-effectiveness of hub-and-spoke telestroke networks for the management of acute ischemic stroke from the hospitals' perspectives
Jeffrey A Switzer, Bart M Demaerschalk, Jipan Xie, et al.
Current Medical Research and Opinion
|
November 11, 2010
Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemia
Eric Q Wu, Annie Guerin, Andrew P Yu, et al.
The American Journal of Managed Care
|
February 12, 2014
Cost utility of hub-and-spoke telestroke networks from societal perspective
Bart M Demaerschalk, Jeffrey A Switzer, Jipan Xie, et al.
Diabetes Care
|
June 27, 2013
Clinical and economic benefits associated with the achievement of both HbA1c and LDL cholesterol goals in veterans with type 2 diabetes
Lizheng Shi, Xin Ye, Mei Lu, et al.
Journal of Managed Care Pharmacy : JMCP
|
September 19, 2007
Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies
Eric Q Wu, Howard G Birnbaum, Huabin F Zhang, et al.
Journal of Medical Economics
|
April 30, 2013
Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis
Juliana Setyawan, Paul Hodgkins, Annie Guérin, et al.
Page
of 21